RaeSedo Selected to Present New Approach to Asthma Treatment at the 2024 ATS Respiratory Innovation Summit prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
WASHINGTON — Male and female patients experienced similar improvements in their severe, uncontrolled asthma with tezepelumab over a 52-week period, according to data presented at the American Thoracic Society International Conference.“Sex-related differences in asthma prevalence and severity are well documented,” Monica Kraft, MD, Murray M. Rosenberg Professor of Medicine and
/PRNewswire/ RaeSedo Inc., a spin-out of the University of Arizona developing novel therapies for asthma, is pleased to announce the award of a Phase 2.
/PRNewswire/ RaeSedo Inc., a spin-out of the University of Arizona developing novel therapies for asthma, is pleased to announce the award of a Phase 2.